News Feed
#politics
#society
#currentevents
#technology
#socialjustice
A space for sharing and discussing news related to global current events, technology, and society.
69465 Members
See All
Crypto
Economics
Culture
Ecology
Support
ALT-WOKE
Gaming
Artificial Life
We'll be adding more communities soon!
FAQ
|
Content Policy
|
Privacy Policy
© 2020 Relevant Protocols Inc.
News Feed
#politics
#society
#currentevents
#technology
#socialjustice
A space for sharing and discussing news related to global current events, technology, and society.
69465 Members
See All
Crypto
Economics
Culture
Ecology
Support
ALT-WOKE
Gaming
Artificial Life
We'll be adding more communities soon!
FAQ
|
Content Policy
|
Privacy Policy
© 2020 Relevant Protocols Inc.
Relevant
Hot
New
Spam
Community: News Feed
Get Started
Login
Relevant
Hot
New
Spam
Community: News Feed
Get Started
Login
0
388
The Rise of White Label Crypto Exchanges: Key Insights and Advantages
linkedin.com ↗︎
1 Comment
#crypto
#exchage
#insights
0
388
The Rise of White Label Crypto Exchanges: Key Insights and Advantages
linkedin.com ↗︎
1 Comment
#crypto
#exchage
#insights
poojanegi99945
@poojanegi99945 • 6 Months Ago
...
0
Reply
Share
poojanegi99945
@poojanegi99945 • 6 Months Ago
...
0
Reply
Share
0
41.3
COVID: new antibody treatment could offer up to 18 months' protection against severe disease
theconversation.com ↗︎
• Rebecca Aicheler
1 Comment
#astrazeneca
#covid-19
#monoclonal antibodies
#coronavirus insights
#coronavirus
#currentevents
0
41.3
COVID: new antibody treatment could offer up to 18 months' protection against severe disease
theconversation.com ↗︎
• Rebecca Aicheler
1 Comment
#astrazeneca
#covid-19
#monoclonal antibodies
#coronavirus insights
#coronavirus
#currentevents
Mr. Keita
@mrkeita • 3 Years Ago
...
>"AstraZeneca’s durable monoclonal antibody treatment has shown promise in phase 3 clinical trials."
0
Reply
Share
Mr. Keita
@mrkeita • 3 Years Ago
...
>"AstraZeneca’s durable monoclonal antibody treatment has shown promise in phase 3 clinical trials."
0
Reply
Share